2019 – Page 20 – Policy & Medicine

FDA Funded Research Shows claim #1 Prescribed Has Value with Consumers

Indivior Indicted in Alleged Multibillion-Dollar Fraud Scheme

Increased Oversight and Penalties for Drug Misclassifications under the Medicaid Services Investment and Accountability Act of 2019

CBO Report: Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid

REMS: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary — Final Guidance

Bipartisanship Returns to Congress?

Is the Future of Healthcare Online?

Maine Gift Ban: Proposed Regulations Issued – $250 Limit on Honorarium

FDA Outlines Plans for Medical Devices with AI

FDA Defends Oversight of Generic Drugs